Abstract
The COVID-19 epidemic has had a significant impact on the Chinese pharmaceutical market, leading to substantial changes in demand, production, supply, and market size. This study aims to analyze the impact on the Chinese pharmaceutical market by examining the evolving market trends during the COVID-19 epidemic. Through relevant literature and data, the following conclusions are drawn: the Chinese pharmaceutical market has undergone significant changes in demand, production, supply, price, and scale due to the epidemic. These factors not only posed considerable challenges to the Chinese pharmaceutical market during the epidemic, prompting the government and enterprises to implement a series of policies to overcome these difficulties, but also presented opportunities and challenges for the development of the Chinese pharmaceutical market. Based on the above analyses, this paper proposes some innovations and suggestions, for example the government should put forward some policies to manage market price fluctuations in some special period, and the state should also cultivate and introduce more innovative talents to help the country innovate in science and technology.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
